SM
ASMB icon

Sabby Management’s Assembly Biosciences ASMB Stock Holding History

Sabby Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,267
Closed -$542K – 299
2016
Q3 		$542K Sell
6,267
-1,263
-17% -$97.6K 0.02% 218
2016
Q2 		$502K Buy
+7,530
New +$494K 0.03% 213
2013
Q3 		– Sell
-11,590
Closed -$1.67M – 200
2013
Q2 		$1.67M Buy
+11,590
New +$1.82M 0.11% 98

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management's ASMB Position: Q4 2016 in Review

Sabby Management sold out of Assembly Biosciences (ASMB) in Q4 2016, closing a stake of 6,267 shares — an estimated $542K sold.

Sabby Management first reported a position in ASMB in Q2 2013 and held it in 3 quarters. The position peaked at $1.67M in Q2 2013. 36 funds tracked by Wall St. Rank hold ASMB as of Q4 2016.

  • Sabby Management reported no remaining Assembly Biosciences position as of Q4 2016 after selling out during the quarter.
  • Sabby Management sold 6,267 Assembly Biosciences shares in Q4 2016, an estimated $542K.
  • Sabby Management first reported a position in Assembly Biosciences in Q2 2013 and held it in 3 quarters.
  • Sabby Management's Assembly Biosciences position peaked at $1.67M in Q2 2013.
  • 36 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2016.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.